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Fractional Flow Reserve Assessment of Left Main Stenosis in the Presence of
Downstream Coronary Stenoses: Validation in Humans
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Background: Fractional ﬂow reserve (FFR) measurement can aid in the assessment of
left main coronary stenosis. We have previously shown in an animal model that the
presence of downstream epicardial stenosis can affect left main FFR measurement.
The aim of this study is to explore the effect of stenosis in a downstream epicardial
artery on left main FFR assessment in humans.
Methods: After elective coronary intervention of either the left anterior descending
(LAD) or left circumﬂex (LCX) artery, an intermediate left main stenosis was created
using an uninﬂated “winged” balloon. Variable stenoses were then created in the
downstream vessel using a balloon inﬂated within the newly placed stent. A total of 67
pairs of left main FFR assessments in 16 patients were obtained, before and after
creation of a stenosis in the downstream vessel, with a pressure wire in the non-
stenosed downstream vessel.
Results: The apparent left main FFR in the presence of downstream stenosis
(FFRapp) was modestly higher than the true FFR in the absence of downstream
stenosis (FFRtrue) (0.820.07vs.0.800.07, p<0.001). The difference between
FFRtrue and FFRapp correlated with composite FFR of the left main plus stenosed
artery (FFRepicardial) (r¼-0.36, p<0.001), and this difference was only signiﬁcant
when FFRepicardial was severe (ﬁgure below). Among the 67 measurements, only 2
(3%) had a difference between FFRtrue and FFRapp of >0.5, and the FFRepicardial
was <0.2 in both cases.Conclusions: A clinically signiﬁcant effect on the FFR assessment of left main
disease with occurs only when the stenosis in the other vessel is severe.
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Single Bolus Regadenoson Injection Versus Central Venous Infusion Of
Adenosine To Induce Maximum Coronary Hyperemia For Measurement Of FFR
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Background: Regadenoson is an A2A-receptor selective hyperemic stimulus known
by its rapid onset and simple method of administration. We compared the hyperemic
effect of single bolus regadenoson injection to central venous adenosine infusion for
measuring Fractional Flow Reserve (FFR). Moreover, time intervals to onset and
duration of steady state maximum hyperemia were studied, central venous versus
peripheral injections of regadenoson were compared, and safety of repeated injections
of regadenoson was investigated.
Methods: Fifty patients with angiographic intermediate CAD scheduled for
measurement of FFR were enrolled. FFR was measured twice by central venous
adenosine (140 mg/kg/min) and twice by central or peripheral venous regadenoson
bolus injection (400 mg) in a randomized sequence.
Results: Patients had a mean age of 658 years and 80% was male. The stenosis under
investigation was located in the LAD, CX, and RCA in 60%, 28% and 11% respec-
tively. There was no difference in FFR measured by adenosine or by regadenoson (R2
¼ 0.981, DFFR ¼ 0.000.02, p<0.001), neither between repeated bolus injections of
regadenoson (R2¼ 0.971, DFFR¼ 0.000.02, p<0.001). The onset of hyperemia was
achieved within 2912s, maximum hyperemia lasted 151s with a wide variation
between 15 and >600s. No noticeable side-effects of the drugs were observed.B188 JACC Vol 62/18/Suppl B j October 27–NovemConclusions: Regadenoson is an excellent alternative for adenosine to induce
maximum hyperemia. Its ease in administration, rapid onset and duration of maximum
hyperemia make it an excellent hyperemic stimulus. Repeated injection of regade-
noson is safe.
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Background: A central tenant of fractional ﬂow reserve (FFR) is that ﬂow increases
following administration of vasodilators. However, animal studies show the increases
in ﬂow are limited to mild stenoses and unobstructed vessels, whilst the incremental
beneﬁt of vasodilator administration to more signiﬁcant stenoses may be negligible. In
this study, we assess this in humans, using FFR as a physiological measure of stenosis
severity over various phases of the cardiac cycle.
Methods: Pressure and ﬂow velocity were simultaneously measured at rest and during
adenosine-mediated hyperemia using intra-coronary wires in 146 stenosis in patients
undergoing stenosis assessment. Resting and hyperemic whole-cycle ﬂow (FlowRwc
and FlowHwc), resting wave-free ﬂow (Flowwfp), and fractional ﬂow reserve were
calculated.
Results: In non-signiﬁcant coronary lesions by FFR, hyperemic whole cycle ﬂow
was consistently higher than resting wave-free ﬂow: D0.140.02m/s in lesions with
FFR 0.81-0.90, and D0.220.04m/s in lesions with FFR 0.91-1.0 (p<0.001 for
both). In contrast, in signiﬁcant lesions by FFR the mean difference in Flowwfp and
FlowHwc was 0.030.01m/s when FFR0.80 and 0.020.01m/s when FFR0.75,
both signiﬁcantly less than when FFR>0.80 or >0.75 (p<0.001). Overall in phys-
iologically signiﬁcant stenoses deﬁned by FFR 0.75 or FFR0.80, resting Flowwfp
represented 100%, and 97% of hyperemic FlowHwc respectively. In contrast, resting
whole cycle ﬂow represented a signiﬁcantly smaller fraction of FlowHwc in signiﬁ-
cant stenoses (76% and 74% respectively, p<0.001 for both) and was signiﬁcantly
lower than Flowwfp for both signiﬁcant and non-signiﬁcant stenoses (p<0.001
for all).
Conclusions: Adenosine does not signiﬁcantly increase ﬂow compared to the wave-
free period in stenoses deﬁned as signiﬁcant by FFR. Adenosine only increases ﬂow
compared to resting whole cycle and wave-free period when stenoses are physio-
logically non-signiﬁcant. This may have important implications for physiological
stenosis assessment.
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Background: There is still much room for improvement in developing a robust
noninvasive model for predicting fractional ﬂow reserve (FFR). We aimed to deter-
mine the application of advanced coronary computed tomography angiography (A-
CCTA) for predicting invasive FFR in intermediate coronary lesions.
Methods: Sixty-one patients with 71 single intermediate coronary lesions (50-80%
stenosis) on CCTA prospectively underwent coronary angiography and FFR.
Advanced anatomical and morphometric plaque analysis was performed based on
CCTA data set to determine optimal criteria for signiﬁcant ﬂow impairment. A
signiﬁcant stenosis was deﬁned as FFR 0.80.
Results: FFR averaged 0.85  0.09, and 19 lesions (27%) were functionally
signiﬁcant. FFR correlated with minimum lumen area (MLA) (r ¼ 0.456,
p <0.001), minimum lumen diameter (MLD) (r ¼ 0.326, p ¼ 0.006), reference LD
(r ¼ 0.245, p¼0.039), plaque burden (r ¼ -0.313, p ¼ 0.008), lumen area stenosis
(r ¼ -0.305, p ¼ 0.01), lesion length (r ¼ -0.692, p <0.001), and plaque volume
(r ¼ -0.668, p <0.001). There was no relationship between FFR and CCTA
morphometric plaque parameters. By multivariate analysis the independent predic-
tors of FFR were lesion length (beta ¼ -0.581, p <0.001), MLA (beta ¼ 0.360, p ¼
0.041), and reference LD (beta ¼ -0.255, p ¼ 0.036). The optimal cutoffs for lesion
length, MLA, MLD, reference LD, and lumen area stenosis were >18.5mm,ber 1, 2013 j TCT Abstracts/POSTER/Physiologic Lesion Assessment
www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PM3.0mm2, 2.1mm, 3.2mm, and >69%, respectively (max. sensitivity: 100%,
max. speciﬁcity: 79%).CCTA predictors for invasive FFR as a continous variable
Beta coefﬁcient 95% CI P-value
Lesion location in
LAD
0.157 0.062 to 0.003 0.071
Mean reference LD 0.255 -0.094 to -0.003 0.036
MLA 0.360 0.001 to 0.069 0.041
MLD 0.042 -0.089 to 0.067 0.780
Lesion length 0.581 0.007 to 0.003 <0.001
Plaque burden 0.131 -0.005 to 0.001 0.152Conclusions: The CCTA-derived anatomical triad of lesion length, MLA, and
reference segment LD independently predicts invasively determined FFR. CCTA
might be used as a gatekeeper to exclude signiﬁcant ischemia in the subset of lesions
with 50% luminal narrowing.
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Background: Coronary ﬂow velocity reserve (CFVR) has been considered an
important diagnostic index of the functional capacity of coronary arteries. A donor
artery providing collateral distal to a chronic total occlusion (CTO) may have
diminished blood ﬂow. The aim of this study was to evaluate, by noninvasive CFVR,
whether the blood ﬂow of donor artery reverts to normal after successful percutaneous
coronary intervention (PCI) of CTO.
Methods: We evaluated 25 patients (20 men, 5 women; mean age 57.514.1 years)
who underwent successful PCI of right coronary artery (RCA) CTO, whose collateral
provided by left anterior descending artery (LAD). The coronary ﬂow velocities in the
distal LAD were measured using transthoracic Doppler echocardiography at rest and
during hyperemia induced by intravenous infusion of adenosine at 3 time periods;
before (basal), 24 hours after (early) and within 3 months (late) of successful PCI.
CFVR was calculated as the hyperemic to resting coronary diastolic peak velocities
ratio.
Results: There was no difference between basal, early and late left ventricular ejection
fraction values (53.510.2, 53.39.5, 53.311.2, respectively). The CFVR at third
month was signiﬁcantly increased compared to the basal and early CFVR (1.80.3 vs.
2.30.3; p <0.001 and 1.80.2 vs. 2.30.3; p<0.001, respectively). On the other
hand, there was no signiﬁcant difference between basal and early CFVR (1.80.3 vs.
1.80.2; p¼0.89, respectively).
Table 1. LAD CFVR values before and after recanalization of RCA CTO
Basal Early Late P1 P2 P3
CFVR 1.80.3 1.80.2 2.30.3 0.89 <0.001 <0.001








SConclusions: In this study, we have shown that successful recanalization of CTO
results in increased CFVR-indicated blood ﬂow in the donor artery within 3 months.
TCT-623
Area Of Myocardium At Risk And Lesion Length Are Predictors Of
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Background: Angiographic evaluation of diameter stenosis has only modest
predictive value for functionally signiﬁcant coronary-artery-stenoses as assessed by
fractional-ﬂow-reserve (FFR). Lesion length and assessment of area of myocardium
at risk (BARI-myocardial-jeopardy-index) subtended by the stenotic coronary
arteries are also predictors of functionally signiﬁcant coronary-artery-stenoses. We
compared the diagnostic accuracy of minimal-lumen-diameter (MLD), lesion length
and BARI-myocardial-jeopardy-index (MJI) in prediction of signiﬁcantly reduced
FFR (0.8).JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrMethods: We assessed consecutive patients who underwent coronary angiography
and FFR. Lesion length and MLD were assessed by QCA. Estimation of area-
of-myocardium at risk subtended by coronary stenoses was performed using the
BARI-MJI. Coronary stenoses were classiﬁed as functionally signiﬁcant when FFR
was  0.8.
Results: 196 consecutive patients (age 65.6  10.9; 69% male, 306 vessels) were
included. 117 vessels (51%) had FFR  0.8. The BARI MJI was 34.2  13.8 in
vessels with FFR 0.8 compared to 21.8  11.0 in vessels with FFR >0.8 (p<0.001).
The mean lesion length in vessels with FFR 0.8 was 18.7 vs 9.37 mm in vessels with
FFR >0.8 (P <0.001). The MLD in vessels with FFR 0.8 was 1.16  0.458 mm
compared to 1.51  0.470 mm in vessels with FFR > 0.8 (P <0.001). The boot-
strapped Harrell's c-statistic of BARI MJI, lesion length and MLD in predicting
signiﬁcant FFR were 0.76 (0.71-0.82), 0.75 (0.70-0.80) and 70 (0.65-0.75)
respectively.
Conclusions: Diameter stenosis alone has modest predictive value of signiﬁcant FFR.
Area of myocardium at risk and lesion length are also predictors of functionally
signiﬁcant coronary artery stenoses.
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Background: Instant wave-free ratio (iFR) is a new index of coronary stenosis
severity calculated without the need for vasodilators. iFR uses automated algorithms
over baseline pressure traces to detect a phase in the cardiac cycle when resistance is
lowest and most stable. Previous studies have calculated iFR ofﬂine, and the feasi-
bility of real-time iFR measurement has never been assessed. In this study we explore
the real-time iFR measurement in humans undergoing invasive functional assessment
of intermediate coronary stenoses.
Methods: 392 angiographically intermediate stenoses from 16 centers in Europe, Asia
and Africa were included. iFR and FFR were measured in real-time, by clinicians, on
clinically available consoles. The agreement between iFR and FFR was calculated for
both clinical (0.80) and ischaemic (0.75) FFR cut-offs.
Results: iFR and FFR maintain a close level of agreement when both are measured by
clinicians in real-time (for a ischaemic 0.75 FFR cut-off: ROCAUC 0.90, classiﬁca-
tion match 88%; for a clinical 0.80 FFR cut-off: ROCAUC 0.87, classiﬁcation match
80%; if the FFR 0.75-0.80 gray zone is accounted for: ROCAUC 0.93, classiﬁcation
match 92%). The diagnostic performance of iFR is summarized in Figure 1.Conclusions: iFR measurement is feasible and practical for clinicians in a real world
setting. By simplifying stenosis evaluation, iFR may expand adoption of physiology-
guided revascularization.acts/POSTER/Physiologic Lesion Assessment B189
